Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Assets: 2022-2025

Historic Return on Assets for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to -1.81%.

  • bioAffinity Technologies' Return on Assets fell 53.00% to -1.81% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.81%, marking a year-over-year decrease of 53.00%. This contributed to the annual value of -1.23% for FY2024, which is 45.00% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Return on Assets stood at -1.81%, which was up 20.32% from -2.27% recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Return on Assets peaked at -0.62% during Q4 2022, and registered a low of -2.27% during Q2 2025.
  • In the last 3 years, bioAffinity Technologies' Return on Assets had a median value of -1.19% in 2024 and averaged -1.27%.
  • Data for bioAffinity Technologies' Return on Assets shows a maximum YoY slumped of 108bps (in 2025) over the last 5 years.
  • Over the past 4 years, bioAffinity Technologies' Return on Assets (Quarterly) stood at -0.62% in 2022, then dropped by 24bps to -0.86% in 2023, then plummeted by 52bps to -1.38% in 2024, then crashed by 53bps to -1.81% in 2025.
  • Its last three reported values are -1.81% in Q3 2025, -2.27% for Q2 2025, and -1.61% during Q1 2025.